| Validation of the academic research consortium high bleeding risk definition in contemporary PCI patients D Cao, R Mehran, G Dangas, U Baber, S Sartori, R Chandiramani, ... Journal of the American College of Cardiology 75 (21), 2711-2722, 2020 | 187 | 2020 |
| Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation GG Stefanini, S Stortecky, D Cao, J Rat-Wirtzler, CJ O'Sullivan, S Gloekler, ... European heart journal 35 (37), 2530-2540, 2014 | 185 | 2014 |
| Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis M Chiarito, J Sanz-Sánchez, F Cannata, D Cao, M Sturla, C Panico, ... The Lancet 395 (10235), 1487-1495, 2020 | 158 | 2020 |
| A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an … R Mehran, R Owen, M Chiarito, U Baber, S Sartori, D Cao, J Nicolas, ... The Lancet 398 (10315), 1974-1983, 2021 | 119 | 2021 |
| Contrast-induced acute kidney injury R Chandiramani, D Cao, J Nicolas, R Mehran Cardiovascular intervention and therapeutics 35, 209-217, 2020 | 106 | 2020 |
| P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events F Gragnano, D Cao, L Pirondini, A Franzone, HS Kim, M von Scheidt, ... Journal of the American College of Cardiology 82 (2), 89-105, 2023 | 101 | 2023 |
| Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR J Escaned, D Cao, U Baber, J Nicolas, S Sartori, Z Zhang, G Dangas, ... European heart journal 42 (45), 4624-4634, 2021 | 95 | 2021 |
| On the modeling of patient-specific transcatheter aortic valve replacement: a fluid–structure interaction approach G Luraghi, F Migliavacca, A García-González, C Chiastra, A Rossi, D Cao, ... Cardiovascular engineering and technology 10, 437-455, 2019 | 93 | 2019 |
| Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials F Costa, C Montalto, M Branca, SJ Hong, H Watanabe, A Franzone, ... European Heart Journal 44 (11), 954-968, 2023 | 86 | 2023 |
| 3-or 1-month DAPT in patients at high bleeding risk undergoing everolimus-eluting stent implantation R Mehran, D Cao, DJ Angiolillo, S Bangalore, DL Bhatt, J Ge, J Hermiller, ... Cardiovascular Interventions 14 (17), 1870-1883, 2021 | 85 | 2021 |
| Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey D Cao, R Chandiramani, M Chiarito, BE Claessen, R Mehran European Heart Journal 42 (4), 339-351, 2021 | 83 | 2021 |
| Radial versus femoral access for coronary interventions: an updated systematic review and meta‐analysis of randomized trials M Chiarito, D Cao, J Nicolas, A Roumeliotis, D Power, R Chandiramani, ... Catheterization and Cardiovascular Interventions 97 (7), 1387-1396, 2021 | 82 | 2021 |
| Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management D Cao, R Chandiramani, D Capodanno, JS Berger, MA Levin, MT Hawn, ... Nature Reviews Cardiology 18 (1), 37-57, 2021 | 76 | 2021 |
| Duration of dual antiplatelet therapy for patients at high bleeding risk undergoing PCI M Valgimigli, D Cao, DJ Angiolillo, S Bangalore, DL Bhatt, J Ge, ... Journal of the American College of Cardiology 78 (21), 2060-2072, 2021 | 62 | 2021 |
| Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: a systematic review and meta-analysis M Chiarito, D Cao, F Cannata, C Godino, C Lodigiani, G Ferrante, ... JAMA cardiology 3 (3), 234-241, 2018 | 61 | 2018 |
| Lipid management in patients presenting with acute coronary syndromes: a review BE Claessen, P Guedeney, CM Gibson, DJ Angiolillo, D Cao, N Lepor, ... Journal of the American Heart Association 9 (24), e018897, 2020 | 50 | 2020 |
| Clinical outcomes and revascularization strategies in patients with low-flow, low-gradient severe aortic valve stenosis according to the assigned treatment modality CJ O’Sullivan, L Englberger, N Hosek, D Heg, D Cao, GG Stefanini, ... JACC: Cardiovascular Interventions 8 (5), 704-717, 2015 | 47 | 2015 |
| Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7 M Gaudino, A Di Franco, D Cao, G Giustino, CN Bairey Merz, SE Fremes, ... Journal of the American College of Cardiology 79 (14), 1407-1425, 2022 | 46 | 2022 |
| Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside J Nicolas, CA Pivato, M Chiarito, F Beerkens, D Cao, R Mehran Cardiovascular research 119 (3), 631-646, 2023 | 45 | 2023 |
| Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis AH Tavenier, R Mehran, M Chiarito, D Cao, CA Pivato, J Nicolas, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (5), 492-502, 2022 | 44 | 2022 |